会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明授权
    • 2-(3-Iodo-2-propynyloxy)-ethyl carbamates, the preparation thereof, and
their use as antimicrobial agents
    • 2-(3-碘-2-丙炔氧基) - 乙基氨基甲酸酯,其制备及其作为抗微生物剂的用途
    • US4474807A
    • 1984-10-02
    • US427881
    • 1982-09-29
    • Werner GerhardtRudolf Lehmann
    • Werner GerhardtRudolf Lehmann
    • A01N47/12A01N47/18A01N47/20A01N47/24C07C125/065
    • A01N47/24A01N47/12A01N47/18A01N47/20
    • This invention is directed to novel antimicrobial agents. More particularly, this invention is directed to 2-(3-iodo-2-propynyloxy)-ethyl carbamates of the formula ##STR1## wherein R is hydrogen, linear or branched alkyl of from 1 to 12 carbon atoms, cycloalkyl of from 4 to 8 carbon atoms, aryl, substituted aryl, aralkyl, or arylsulfonyl;R.sup.1 and R.sup.2, which may be the same or different, each are hydrogen, linear or branched alkyl or alkenyl of from 1 to 6 carbon atoms, or cycloalkyl of from 5 to 7 carbon atoms, or R.sup.1 and R.sup.2, taken together, represent --(CH.sub.2).sub.m --, in which m is an integer of from 4 to 6; andR.sup.3, R.sup.4, R.sup.5, and R.sup.6, which may be the same or different, each represent hydrogen, alkyl of from 1 to 4 carbon atoms, or aryl, or CCl.sub.3, or R.sup.3 and R.sup.5 or R.sup.4 and R.sup.6, taken together, represent --(CH.sub.2).sub.n --, in which n is an integer of from 3 to 5,as well as a process for their preparation and their use as antimicrobial agents.
    • 本发明涉及新型抗微生物剂。 更具体地,本发明涉及式(I)的式(I)的2-(3-碘-2-丙炔氧基) - 乙基氨基甲酸酯,其中R是氢,具有1至12个碳原子的直链或支链烷基, 4至8个碳原子,芳基,取代的芳基,芳烷基或芳基磺酰基; R 1和R 2可以相同或不同,各自为氢,具有1至6个碳原子的直链或支链烷基或烯基或5至7个碳原子的环烷基,或者R 1和R 2一起表示 - (CH 2)m - ,其中m为4-6的整数; 和可以相同或不同的R 3,R 4,R 5和R 6各自表示氢,1至4个碳原子的烷基或芳基或CCl 3,或R 3和R 5或R 4和R 6一起表示 - (CH 2)n - ,其中n为3至5的整数,以及其制备方法及其作为抗微生物剂的用途。
    • 4. 发明授权
    • Retard systems for the sustained release of medicinal and/or biological
valuable materials from a depot carrier material
    • 阻止用于从贮库载体材料持续释放药物和/或生物有价物质的系统
    • US5538738A
    • 1996-07-23
    • US133205
    • 1993-10-18
    • Wolfgang RitterRudolf LehmannRainer Sorg
    • Wolfgang RitterRudolf LehmannRainer Sorg
    • A61K9/00A61K20060101A61K9/20A61K9/22A61K47/30A61K47/32A61K47/34A61L26/00A61K9/10A61K9/14
    • A61K9/2027A61K9/204A61L26/0066A61L2300/406A61L2300/602Y10S424/13Y10T428/31786
    • The invention relates to the use of free radical-reactive cross-linker components based on olefinically unsaturated esters of lower hydroxycarboxylic acids and/or oligomers thereof for modifying depot materials, and especially retard systems, which contain medicinal and/or biological valuable materials in admixture with a carrier material in a sustained release form. The cross-linkers are present as polymer compounds in the application form of the retard system and may be provided in the retard system or depot material to be applied in a largely homogeneous as well as in a non-uniform distribution. The invention also relates to retard systems which contain medicinal and/or biological valuable materials and have been based on oligomer and/or polymer compounds of lower hydroxycarboxylic acids as carrier materials providing a sustained release of the active substance. The retard systems and/or depot materials are modified with polymer compounds prepared from olefinically unsaturated esters of lower hydroxycarboxylic acids and/or oligomers thereof.
    • PCT No.PCT / EP92 / 00825 Sec。 371日期:1993年10月18日 102(e)日期1993年10月18日PCT提交1992年4月11日PCT公布。 WO92 / 18108 PCT出版物 日期:1992年10月29日本发明涉及使用基于低级羟基羧酸和/或其低聚物的烯属不饱和酯的自由基 - 反应性交联剂组分来改性储存材料,特别是延迟体系,其包含药物和/或 生物有价值的材料与持续释放形式的载体材料混合。 交联剂以延迟体系的应用形式作为聚合物化合物存在,并且可以在延迟体系或储库材料中提供以在很大程度上均匀和非均匀分布中施用。 本发明还涉及包含药物和/或生物有价值物质并且基于低级羟基羧酸的低聚物和/或聚合物化合物作为提供活性物质的持续释放的载体材料的延迟系统。 延迟系统和/或贮库材料用由低级羟基羧酸和/或其低聚物的烯属不饱和酯制备的聚合物改性。
    • 5. 发明授权
    • Cleaning and disinfecting agent containing an N-substituted propylene
glutamic acid or derivative thereof, and an antimicrobially active
compound
    • 包含N-取代的丙烯谷氨酸或其衍生物的清洁和消毒剂和抗微生物活性化合物
    • US5403505A
    • 1995-04-04
    • US923969
    • 1992-11-12
    • Klaus HachmannKarlheinz DischKlaus-Peter BansemirHubert SchwiddenStephanie KauppCarsten FrieseRudolf LehmannHans T. Leinen
    • Klaus HachmannKarlheinz DischKlaus-Peter BansemirHubert SchwiddenStephanie KauppCarsten FrieseRudolf LehmannHans T. Leinen
    • A61L2/18C11D1/645C11D3/48
    • C11D3/48A61L2/18C11D1/645
    • An aqueous cleaning and disinfecting concentrate comprisingA) at lease one reaction product ofa) an N-substituted propylene diamine of formula IR.sup.1 --NH--(CH.sub.2).sub.3 --NH.sub.2 (I) in which R.sup.1 is a C.sub.8 -C.sub.18 alkyl group andb) glutamic acid or a glutamic acid derivative of formula IIR.sub.2 --O--CO--(CH.sub.2).sub.2 --CH(NH.sub.2)--COOH (II) in which R.sup.2 is hydrogen or a C.sub.1 -C.sub.4 alkyl group, wherein the said reaction product is optionally ethoxylated and/or propoxylated, and is optionally in the form of a salt with an organic or inorganic acid;B) at least one of the following antimicrobially active compounds:i) a quaternary ammonium compound of formula III ##STR1## in which R.sup.3 and R.sup.4 independently of one another represent alkyl radicals containing 1 to 3 carbon atoms or benzyl radicals, or halogenated or alkylated benzyl radicals containing 6 to 22 carbon atoms, and X.sup.- is an anion;ii) a phenol;iii) a biguanide;(iv) a quaternary phosphonium compound of formula IV ##STR2## in which R.sup.7, R.sup.8, R.sup.9 and R.sup.10 are each independently an alkyl, alkenyl, aryl, or alkaryl group having from 1 to 16 carbon atoms, and Y.sup.- is an anion; andC) at least one low foaming surfactant.The invention also relates to the diluted concentrates, and to the method of use of the diluted concentrates, especially for the disinfection of medical equipment.
    • PCT No.PCT / EP91 / 00400 Sec。 371日期:1992年11月12日 102(e)日期1992年11月12日PCT 1991年3月4日PCT公布。 出版物WO91 / 日本1991年9月19日。一种水性清洁和消毒浓缩物,其包含A)至少一种反应产物,其a)N-取代的丙二胺,式I R1-NH-(CH2)3-NH2(Ⅰ),其中R1是 C 8 -C 18烷基和b)谷氨酸或式II的R 2 -O-CO-(CH 2)2 -CH(NH 2)-COOH(II)的谷氨酸衍生物,其中R 2是氢或C 1 -C 4烷基 基团,其中所述反应产物任选被乙氧基化和/或丙氧基化,并且任选地是与有机或无机酸形式的盐; B)至少一种以下抗微生物活性化合物:i)式III的季铵化合物(III),其中R 3和R 4彼此独立地表示含有1至3个碳原子的烷基或苄基,或 含有6-22个碳原子的卤代或烷基化苄基,X-是阴离子; ii)苯酚; iii)双胍; (iv)式IV的季鏻化合物其中R 7,R 8,R 9和R 10各自独立地为具有1至16个碳原子的烷基,烯基,芳基或烷芳基,Y-为 阴离子 和C)至少一种低发泡表面活性剂。 本发明还涉及稀释浓缩物,以及稀释浓缩物的使用方法,特别是用于医疗设备的消毒。